Rigel Pharmaceuticals (RIGL) Asset Utilization Ratio (2011 - 2026)
Rigel Pharmaceuticals' quarterly Asset Utilization Ratio came in at 0.59 in Q1 2026, down 50.72% year-on-year from 1.19 in Q1 2025, and down 24.35% quarter-over-quarter from 0.78 in Q4 2025.
Rigel Pharmaceuticals has reported Asset Utilization Ratio for 15 years, with the latest figure at 0.59 in Q1 2026.
- For the quarter ending Q1 2026, Asset Utilization Ratio fell 50.72% year-over-year to 0.59; the trailing twelve-month figure through Mar 2026 stood at 0.59 (down 50.72% YoY), and the FY2025 full-year result was 0.87, down 31.88% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 0.59, down from 0.78 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 1.4 in Q2 2025, with the low at 0.54 in Q1 2022.
- Average Asset Utilization Ratio over 5 years is 0.98, with a median of 1.01 recorded in 2023.
- Year-over-year, Asset Utilization Ratio soared 87.13% in 2023 and plunged 50.72% in 2026.
- Tracing RIGL's Asset Utilization Ratio over 5 years: stood at 0.96 in 2022, then climbed by 4.45% to 1.01 in 2023, then rose by 17.57% to 1.18 in 2024, then sank by 34.14% to 0.78 in 2025, then dropped by 24.35% to 0.59 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.59 (Q1 2026), 0.78 (Q4 2025), and 1.26 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.60 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.47 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 0.29 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.37 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.85 |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn | 0.59 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.59 |
| Dec 31, 2025 | 0.78 |
| Sep 30, 2025 | 1.26 |
| Jun 30, 2025 | 1.40 |
| Mar 31, 2025 | 1.19 |
| Dec 31, 2024 | 1.18 |
| Sep 30, 2024 | 1.18 |
| Jun 30, 2024 | 1.02 |
| Mar 31, 2024 | 0.99 |
| Dec 31, 2023 | 1.01 |
| Sep 30, 2023 | 1.14 |
| Jun 30, 2023 | 1.05 |
| Mar 31, 2023 | 1.00 |
| Dec 31, 2022 | 0.96 |
| Sep 30, 2022 | 0.73 |
| Jun 30, 2022 | 0.64 |
| Mar 31, 2022 | 0.54 |
| Dec 31, 2021 | 0.84 |
| Sep 30, 2021 | 0.76 |
| Jun 30, 2021 | 0.69 |
| Mar 31, 2021 | 0.82 |
| Dec 31, 2020 | 0.93 |
| Sep 30, 2020 | 0.81 |
| Jun 30, 2020 | 0.77 |
| Mar 31, 2020 | 0.70 |
| Dec 31, 2019 | 0.39 |
| Sep 30, 2019 | 0.52 |
| Jun 30, 2019 | 0.40 |
| Mar 31, 2019 | 0.37 |
| Dec 31, 2018 | 0.31 |
| Sep 30, 2018 | 0.02 |
| Jun 30, 2018 | -0.01 |
| Sep 30, 2017 | 0.10 |
| Jun 30, 2017 | 0.11 |
| Mar 31, 2017 | 0.21 |
| Dec 31, 2016 | 0.24 |
| Sep 30, 2016 | 0.28 |
| Jun 30, 2016 | 0.34 |
| Mar 31, 2016 | 0.26 |
| Dec 31, 2015 | 0.21 |
| Sep 30, 2015 | 0.18 |
| Jun 30, 2015 | 0.09 |
| Mar 31, 2015 | 0.06 |
| Dec 31, 2013 | 0.03 |
| Jun 30, 2013 | 0.01 |
| Dec 31, 2012 | 0.01 |
| Sep 30, 2012 | 0.01 |
| Jun 30, 2012 | 0.03 |
| Mar 31, 2012 | 0.02 |
| Dec 31, 2011 | 0.02 |
| Sep 30, 2011 | 0.02 |